The immune-opioid axis in prediabetes: predicting prediabetes with insulin resistance by plasma interleukin-10 and endomorphin-2 to kappa-opioid receptors ratio
Open Access
- 7 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetology & Metabolic Syndrome
- Vol. 13 (1), 1-11
- https://doi.org/10.1186/s13098-021-00677-w
Abstract
Background: Prediabetes is characterized by a hemoglobin A1c of 5.7–6.4% and fasting blood glucose of 100–125 mg/dl. A high percentage of prediabetes subjects develop type 2 diabetes mellitus in the next years. The effects of opioid peptides and their receptors, in addition to immunological cytokines, on prediabetes are not well understood. Therefore, molecular, physiological, and clinical studies are required to link the opioid system, immune system, and insulin resistance (IR) in prediabetes. We hypothesize that opioid peptides (endomorphin-2 (EM2), and β-endorphin (βEP)), and their receptors (µ-opioid receptors (MOR) and κ-opioid receptors (KOR)), in addition to the inflammatory cytokines (IL-6) and anti-inflammatory cytokine (IL-10), affect IR parameters in patients with prediabetes. Methods: Sixty prediabetes patients with IR (prediabetes+IR) and sixty prediabetes patients without IR (prediabetes-IR), in addition to 58 controls, have participated in the study. IL-6, IL-10, EM2, βEP, MOR, and KOR were measured by the ELISA technique. Results: In general, most prediabetes subjects have dyslipidemia. The IL-6, IL-10, β-endorphin, MOR, and endomorphin-2 were higher in the prediabetes subgroups than the control group. The immune system was activated in the prediabetes in an IR-dependent manner. Prediabetes+IR can be predicted by the increased levels of IL-10, βEP, and EM2 and by the combination of IL-10 and EM2/KOR with good sensitivity and specificity. Conclusion: Opioid peptides and their receptors were upregulated in patients with prediabetes, depending on the significance of IR and the immune cytokines. The intercorrelation between the immune system, EOS, and insulin in prediabetes was confirmed.Keywords
This publication has 59 references indexed in Scilit:
- Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and TreatmentFrontiers in Endocrinology, 2013
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomersJCI Insight, 2012
- Mediation of Endogenous β-Endorphin in the Plasma Glucose-Lowering Action of Herbal Products Observed in Type 1-Like Diabetic RatsEvidence-Based Complementary and Alternative Medicine, 2011
- The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine SystemsEndocrine Reviews, 2009
- Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunityCurrent Opinion in Pharmacology, 2009
- The MOR-1 Opioid Receptor Regulates Glucose Homeostasis by Modulating Insulin SecretionMolecular Endocrinology, 2009
- Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosisJCI Insight, 2009
- Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter?Lipids in Health and Disease, 2008
- Effects of flavonoids on sphingolipid turnover in the toxin-damaged liver and liver cellsLipids in Health and Disease, 2008
- Imaging of opioid receptors in the central nervous systemBrain, 2007